Novartis' 2003 'R&D Day'
18. November 2003 23:41 ET
|
Novartis
BASEL, Switzerland, Nov. 19, 2003 (PRIMEZONE) -- Novartis will today present its pharmaceutical pipeline to the media and financial community at our annual 'R&D Day' event in New York.
Please...
Novartis' 2003 "R&D day"
17. November 2003 06:14 ET
|
Novartis
BASEL, Switzerland, Nov. 17, 2003 (PRIMEZONE) -- To the Editors
Novartis' 2003 "R&D day"
Basel, 17 November 2003
On Wednesday, 19 November 2003 Novartis will present its pharmaceutical...
Novartis -- UK and Australian Health Authorities Endorse Use of Glivec(r) for First-line Treatment of Chronic Myeloid Leukemia Patients
30. Oktober 2003 01:45 ET
|
Novartis
BASEL, Switzerland, Oct. 30, 2003 (PRIMEZONE) -- Health authorities in the UK and Australia (the National Institute for Clinical Excellence (NICE) and the Minister of Health and Ageing,...
Novartis outpaces the market with double-digit sales growth and further market share gains in the first nine months of 2003
20. Oktober 2003 01:23 ET
|
Novartis
BASEL, Switzerland, Oct. 20, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS):
-- Group nine-month sales up 18%; Pharmaceuticals climbs 18% and continues
to outpace the market; Sandoz posts 67% sales...
Novartis Nine-month and third-quarter results 2003
16. Oktober 2003 04:36 ET
|
Novartis
BASEL, Switzerland, Oct. 16, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) Nine-month and third-quarter results 2003 now available Online.
Please see full press release under the following link:...
Novartis partners with Sankyo on gastro-intestinal drug development program
08. Oktober 2003 01:11 ET
|
Novartis
BASEL, Switzerland, Oct. 08, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) has signed an agreement with Sankyo (TSE: 4501) of Japan to co-develop and subsequently commercialize a treatment for...
Novartis launches generic omeprazole in the US
19. August 2003 01:51 ET
|
Novartis
BASEL, Switzerland, August 19, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced today that its generics unit Sandoz is launching a generic form of the anti-ulcer treatment Prilosec(r) (omeprazole)...
Novartis: First-half and Second Quarter Results 2003
21. Juli 2003 01:22 ET
|
Novartis
BASEL, Switzerland, July 21, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) delivers strong first-half performance and continues to gain market share.
- Group sales up 20%; Pharmaceuticals climbs 18%,...
Novartis Pre-Announcement First-half and second-quarter results 2003
17. Juli 2003 11:01 ET
|
Novartis
BASEL, Switzerland, July 17, 2003 (PRIMEZONE) -- Please note that Novartis International AG (NYSE:NVS) will publish its Group financial results for the first-half and second-quarter of 2003 on Monday...
Novartis and GlaxoSmithKline reach settlement in Augmentin ITC lawsuit
10. Juli 2003 01:42 ET
|
Novartis
BASEL, Switzerland, July 10, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced that its affiliate companies have reached an agreement with GlaxoSmithKline (NYSE:GSK) over lawsuits related to GSK's...